News Archive

SomaLogic receives Gates Foundation Grand Challenges Tuberculosis Biomarkers Grant

SomaLogic, Inc., announced today that it will receive a tuberculosis (TB) biomarkers grant through the Bill & Melinda Gates Foundation’s Grand Challenges in Global Health program, an initiative that seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world. Urs Ochsner, head of the Infectious Diseases Research Group at SomaLogic, will pursue an innovative research project to identify and validate TB biomarkers, titled SOMAmer-based detection of tuberculosis biomarkers.

read more

SomaLogic announces collaboration with Novartis

SomaLogic announces collaboration with Novartis 10/18/2011 SomaLogic Announces Research Agreement with Leading Global Pharmaceutical Company to Accelerate Pharmaceutical Discovery and Development Powerful proteomic technology to be applied to biomarker discovery,...

read more

SomaLogic and New England Biolabs Agree on SOMAmer Use in PCR Products

SomaLogic, Inc. and New England Biolabs, Inc. (NEB) announced today that they have entered into an exclusive licensing agreement whereby SomaLogic will provide specific SOMAmers as critical and unique reagents in several current and future NEB nucleic acid amplification and polymerase chain reaction (PCR) products.

read more

Emerald and SomaLogic announce collaboration to image SOMAmer-protein complexes

Emerald BioStructures, a leading provider of integrated structural biology services, and SomaLogic, Inc., a diagnostics and biomarker discovery company, today announced that they have entered into a strategic collaboration for the structure-based design of chemically modified DNA aptamers (“SOMAmers”) and small molecule therapeutics, based on crystal structures of important protein targets bound to high affinity SOMAmers.

read more